Beauty Health (NASDAQ:SKIN) Announces Earnings Results

Beauty Health (NASDAQ:SKIN) issued its earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01, FiscalAI reports. The business had revenue of $82.40 million during the quarter, compared to analysts’ expectations of $78.07 million. Beauty Health had a negative net margin of 3.87% and a negative return on equity of 19.70%.

Beauty Health Stock Performance

Shares of SKIN traded down $0.07 during mid-day trading on Thursday, hitting $1.06. 905,859 shares of the company traded hands, compared to its average volume of 608,951. The stock has a market cap of $135.15 million, a price-to-earnings ratio of -4.82 and a beta of 1.20. The stock has a 50-day moving average price of $1.28 and a two-hundred day moving average price of $1.53. Beauty Health has a 1 year low of $0.78 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 5.53, a quick ratio of 4.07 and a current ratio of 4.98.

Wall Street Analysts Forecast Growth

SKIN has been the subject of several analyst reports. TD Cowen raised their price target on shares of Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a research report on Wednesday, January 21st. Zacks Research downgraded Beauty Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 21st. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a report on Wednesday, January 14th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $2.40.

Hedge Funds Weigh In On Beauty Health

Institutional investors and hedge funds have recently modified their holdings of the company. Public Employees Retirement System of Ohio purchased a new stake in Beauty Health during the third quarter valued at $26,000. Atom Investors LP purchased a new position in Beauty Health in the fourth quarter worth about $29,000. Franklin Resources Inc. purchased a new position in Beauty Health in the third quarter worth about $31,000. Ieq Capital LLC bought a new stake in shares of Beauty Health during the 4th quarter valued at about $33,000. Finally, Zacks Investment Management purchased a new stake in shares of Beauty Health during the 3rd quarter valued at about $35,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.